A drug that was approved by the FDA over 70 years ago could be helpful against lung injury caused by COVID-19.
The drug that experts think may help is disulfiram.
How can it help?
Disulfiram is expected to slow the formation of fibrosis in the lungs of COVID-19 patients. Find details of the study here.
The effectiveness of this drug for COVID-19 patients is being tested in golden hamsters.
Infected hamsters that received disulfiram treatment showed changes in gene activity that suggest a sizable reduction of the harmful inflammatory response.
This drug is more protective to our lungs than dexamethasone. Dexamethasone is the standard severe-COVID-19 treatment.
The use of this drug could be critical for those suffering lung damage from COVID.
Some researchers have started small clinical trials of disulfiram in COVID-19 patients. The trials for these have not yet been published.